NEW YORK, Dec. 18, 2013 /PRNewswire/ -- Levi &
Korsinsky is investigating the Board of Directors of Solta Medical,
Inc. ("Solta Medical") (NasdaqGS: SLTM) for possible breaches of
fiduciary duty and other violations of state law in connection with
the sale of the Company to Valeant Pharmaceuticals International,
Inc. (NYSE: VRX).
(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO
)
Click here to learn more about the action
http://zlk.9nl.com/solta-medical-sltm/, or call:
877-363-5972. There is no cost or obligation to you.
Under the terms of transaction, Solta Medical shareholders will
receive $2.92 in cash for each share
of Solta Medical stock they own. The transaction has a total
approximate value of $250 million.
The investigation concerns whether the Solta Medical Board of
Directors breached their fiduciary duties to stockholders by
failing to adequately shop the Company before agreeing to enter
into this transaction, and whether Valeant Pharmaceuticals
International, Inc. is underpaying for Solta Medical shares. In
particular, at least one analyst set a price target for Solta
Medical stock at $4.00 per share.
If you own Solta Medical common stock and wish to obtain
additional information, please contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972, or visit http://zlk.9nl.com/ solta-medical-sltm/.
Levi & Korsinsky is a national firm with offices in
New York, New Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. For more information, please
feel free to contact any of the attorneys listed below. Attorney
advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com
SOURCE Levi & Korsinsky, LLP